Trial
NCT03147040
AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
The Netherlands Cancer Institute
Collaborators
Roche Pharma AG
Condition
Breast Cancer
Intervention
Carboplatin
Why stopped
At interim analysis insufficient benefit was observed to continu the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-19